Healthcare >> CEO Interviews >> May 27, 2003
DR. FRANCESCO BELLINI is Chief Executive Officer of Neurochem
Inc. He is the author or co-author of some 20 patents and has
published numerous articles and papers based on his research. Dr.
Bellini is also Chairman of Picchio International and Picchio
Pharma since 2001. From 1968 to 1984, he had a fruitful career as
a Researcher at the Canadian subsidiary of a multinational
pharmaceutical company. In 1984, Dr. Bellini established the
Biochemcials Division of the Institut Armand-Frappier at the
Universite du Quebec, which specializes in research,
manufacturing and the commercialization of fine chemicals. He
headed up this unit until leaving in 1986 to co-found BioChem
Pharma, an innovative biopharmaceutical company focused on
infectious diseases and cancer. He received his Bachelor of
Science degree from Loyola College (now Concordia University) in
1972 and his Doctorate in Organic Chemistry from University of
New Brunswick in 1977. Profile
Dr. Bellini: Neurochem is a biopharmaceutical company, which
specializes in CNS, with a unique technology. We are after
diseases for which
